Foundry Partners, LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 319 filers reported holding GW PHARMACEUTICALS PLC in Q3 2019. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
Foundry Partners, LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q2 2020$585,000
+35.1%
4,765
-3.7%
0.03%
+20.8%
Q1 2020$433,000
-16.2%
4,9470.0%0.02%
+26.3%
Q4 2019$517,000
-11.2%
4,947
-2.3%
0.02%
-20.8%
Q3 2019$582,000
-62.4%
5,063
-43.6%
0.02%
-60.7%
Q2 2019$1,548,0008,9820.06%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q3 2019
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 86,069$18,668,0008.69%
BARDIN HILL MANAGEMENT PARTNERS LP 170,108$36,897,0006.84%
HARVEST MANAGEMENT LLC 44,100$9,565,0005.72%
Twin Securities, Inc. 39,541$8,576,0005.50%
TIG Advisors, LLC 572,743$124,228,0004.67%
ALPINE ASSOCIATES MANAGEMENT INC. 787,500$170,810,0004.63%
First Trust Capital Management L.P. 105,822$22,953,0004.49%
Pentwater Capital Management LP 2,102,104$455,946,0004.35%
OMNI PARTNERS LLP 403,061$87,424,0004.31%
SPRING CREEK CAPITAL LLC 370,000$80,253,0003.47%
View complete list of GW PHARMACEUTICALS PLC shareholders